Kiltearn Partners LLP Sells 51,900 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Kiltearn Partners LLP lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 37.1% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 88,100 shares of the company’s stock after selling 51,900 shares during the quarter. HCA Healthcare accounts for approximately 3.4% of Kiltearn Partners LLP’s portfolio, making the stock its 12th largest position. Kiltearn Partners LLP’s holdings in HCA Healthcare were worth $28,305,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of HCA. Bangor Savings Bank increased its stake in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare during the 2nd quarter valued at about $28,000. GPS Wealth Strategies Group LLC lifted its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. bought a new stake in HCA Healthcare during the first quarter worth $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 over the last three months. Insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $405.71 on Tuesday. The firm has a market capitalization of $106.26 billion, a price-to-earnings ratio of 20.22, a P/E/G ratio of 1.46 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The stock has a fifty day moving average of $372.34 and a 200 day moving average of $341.21. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $409.42.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same period in the previous year, the business posted $4.29 earnings per share. HCA Healthcare’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, research analysts expect that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Leerink Partners upped their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Barclays raised their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.